Repeat Dose Tolerance Study of Regadenoson in Healthy Subjects
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
This study is to determine the safety, tolerability, and pharmacokinetics of two or three
repeat intravenous (IV) bolus doses of regadenoson administered 10 minutes apart in healthy
supine subjects.